Xu, J., Luo, W., Li, C., & Mei, H. (2023). Targeting CD22 for B-cell hematologic malignancies. Experimental Hematology & Oncology, 12(1), 1. https://doi.org/10.1186/s40164-023-00454-7
Chicago Style (17th ed.) CitationXu, Jia, Wenjing Luo, Chenggong Li, and Heng Mei. "Targeting CD22 for B-cell Hematologic Malignancies." Experimental Hematology & Oncology 12, no. 1 (2023): 1. https://doi.org/10.1186/s40164-023-00454-7.
MLA (9th ed.) CitationXu, Jia, et al. "Targeting CD22 for B-cell Hematologic Malignancies." Experimental Hematology & Oncology, vol. 12, no. 1, 2023, p. 1, https://doi.org/10.1186/s40164-023-00454-7.
Warning: These citations may not always be 100% accurate.